Hologic, a global leader in women’s health, has completed its previously announced acquisition of molecular oncology leader Biotheranostics for approximately $230M. Biotheranostics develops and markets two highly differentiated molecular diagnostic tests for breast and metastatic cancers. “We are very pleased to complete the acquisition of Biotheranostics and look forward to working with our new colleagues to grow in the large, rapidly expanding oncology space,”…
A comprehensive study published in the Journal of the American College of Radiology (JACR) found racial disparities in the utilization of mammography screening overall, and specifically for digital breast tomosynthesis (DBT). The study, “Outcomes by Race in Breast Cancer Screening with Digital Breast Tomosynthesis versus Digital Mammography,” reported breast cancer screening access, utilization and outcomes by race for 385,504 Asian, Black and Caucasian women…
Mammogen, a women’s health startup born at the intersection of data, technology and science has announced the appointment of Elizabeth Cormier-May as Chief Executive Officer and member of the board of directors of Mammogen. She will begin her new role on March 1st, 2021. In her new role, Cormier-May will lead efforts to develop, validate and commercialize the company’s flagship liquid biopsy program for…
BioAesthetics Corporation today announced that it has doubled its initial Series A funding goal of $2.5 million, closed on Dec. 30, 2020, at $5 million to commercialize its NACgraft biologic matrix— a regenerative nipple graft for breast cancer survivors. BioAesthetics’ Series A was co-led by FemHealth Ventures and personally by BioAesthetics’ Director Sandra Coufal, MD, of Sibling Capital Ventures. BioAesthetics’ inaugural product, the NACgraft — for patients…
Hologic announced today that it has agreed to acquire Biotheranostics, a privately held, commercial-stage company that provides molecular diagnostic tests for breast and metastatic cancers, for approximately $230 million, subject to working capital and other customary closing adjustments. “Acquiring Biotheranostics enables us to jump-start our entry into a large, fast-growing oncology adjacency that fits perfectly with our broader corporate focus and passion…
Hologic, a medical technology company primarily focused on improving women’s health, announced today it has completed the acquisition of SOMATEX Medical Technologies, a leader in biopsy site markers and localization technologies, for approximately $64 million. The company was previously owned by E-Med Solutions, a group of investors led by German private equity company Westlake Partners. The transaction supports Hologic’s strategy to provide…
Earlier this week Volpara Health announced two new research studies using their AI-powered software to score breast density objectively and consistently to evaluate its impact in mammography and breast cancer risk assessment. Volpara Density software uses a combination of x-ray physics and machine learning to generate an accurate volumetric measure of breast composition and remains the density measurement tool of choice for…
In our “Starter Story” series we invite femtech founders to share their stories of how it all began. How did they come up with the idea? Where did they meet their cofounders and what was the hardest part of going from 0 to 1? In today’s Starter Story we get to share Brilliantly’s founding story as told by founder Kristen Carbone. Brilliantly‘s mission…
